CJC-1295 WITH DAC 5MG
£41.24 Original price was: £41.24.£29.69Current price is: £29.69.
Alluvi NAD+ 1000mg 2 pen
£195.00 Original price was: £195.00.£175.50Current price is: £175.50.
Alluvi Retatrutide 40MG (4×10MG)
£230.00 Original price was: £230.00.£207.00Current price is: £207.00.
Alluvi Retatrutide 40mg is an experimental triple-hormone receptor agonist designed to support weight management. It targets GIP, GLP-1, and glucagon receptors and is typically administered once weekly to help promote weight loss.
11
People watching this product now!
Research Purpose
- Studied for its potential role in triple receptor activation involving GIP, GLP-1, and glucagon receptors.
- Investigated in laboratory research involving glucose metabolism, energy expenditure, and metabolic regulation.
- Commonly used in studies of appetite regulation, body composition, and endocrine signaling.
- Explored for dose-response and long-duration metabolic research using multi-dose delivery systems.
Ingredients
- Active Compound: Retatrutide
- Total Strength: 40mg
- Configuration: 4 × 10mg doses
- Dosage Form: Pre-filled Multi-Dose Injection Pen
- Purity: ≥99% (Batch Tested)
- Excipients: Proprietary sterile research-grade formulation
Packaging Contents
- 1 × Alluvi Retatrutide 40mg pre-filled multi-dose pen
- Delivers 4 × 10mg doses
- Compatible sterile pen needles (where supplied by the manufacturer)
- Protective pen cap
- Secure protective packaging
- Research information leaflet (manufacturer supplied)
Molecular Structure
- Compound Name: Retatrutide
- Peptide Sequence: Modified 39-amino acid synthetic peptide with a C20 fatty diacid side chain for extended activity
- Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
- Molecular Weight: 4,731.33 g/mol
- Chemical Classification: Triple GIP, GLP-1, and Glucagon Receptor Agonist (Tri-Agonist) Synthetic Peptide
Category: Peptides & Research Products
Related products
Alluvi GLOW GHK CU 70mg 2 pens
BPC-157 + KPV 500mcg
Dihexa Capsules 30 x 10mg
GHK-Cu 100mg
Gift Box Tier 1 Premium Research Collection
Gift Box Tier 2 Essential Research Collection
Tesamorelin 30mg
Tesamorelin 30MG Peptide Pen is a synthetic growth hormone–releasing hormone (GHRH) analogue studied in research environments for its interaction with pituitary signaling pathways and growth hormone regulation mechanisms. Supplied in a ready-to-use peptide pen format for laboratory research use only.

